A new report finds high consumer interest in letting AI assistants handle shopping and bills. But when it comes to checkout, trust quickly shifts from the AI to familiar financial institutions like banks and credit card networks.
The Polish indie game ExeKiller has shown new gameplay, reviving interest in its unique ‘CyberWestern’ setting. Players will take on the role of a bounty hunter in a harsh, choice-driven world.
Andrew Bosworth, head of Meta’s Reality Labs, has called a mandatory in-person all-hands for January 14. This comes after the division lost over $70 billion since 2020 and faced repeated job cuts, including 560 layoffs in early 2025.
Samsung has been silently blocking critical Google Play system updates on its Galaxy phones for months. The company says it’s to avoid issues with its own One UI 8 software, but it leaves a major security gap.
UK Prime Minister Keir Starmer has called for action against X, stating the platform must “get their act together” after reports its Grok AI chatbot generated sexualized deepfakes. The UK’s communications regulator, Ofcom, has begun investigating X for potential violations of the Online Safety Act.
Cisco has patched a medium-severity bug in its Identity Services Engine that allows authenticated admins to read arbitrary files. A public proof-of-concept exploit now exists, raising the risk of in-the-wild attacks. This follows a pattern of serious ISE flaws being exploited.
OpenAI announced ChatGPT Health, a feature that lets users connect medical records for personalized advice. This comes just days after a report linked a teen’s fatal overdose to erroneous ChatGPT guidance. The company insists it’s for support, not diagnosis.
A new review of studies finds that people who stop taking GLP-1 obesity medications like semaglutide regain weight quickly, about 1.8 pounds per month. This suggests many may need to stay on the drugs long-term to maintain results.
The public has until January 21 to comment on a massive R76-billion revenue adjustment for Eskom, which could force electricity tariffs up by about 10.5% this year. The move follows legal challenges over a lack of transparency in previous decisions.
Alpenglow Biosciences is moving its 3D imaging tech from research labs to patient diagnostics. A new partnership with lab network PathNet aims to modernize prostate and bladder cancer testing. The startup also secured fresh funding and is working towards regulatory approval next year.
